A metabolic signal detectable in patient blood has been linked to ALS progression rate and survival, with preclinical data ...
A preclinical study has identified a metabolic vulnerability in aggressive MYC-driven breast cancers, with researchers ...
A new review published in the European Journal of Pharmaceutics and Biopharmaceutics argues that no single local ...
A structure-guided peptide vaccine targeting PCSK9 has reduced LDL cholesterol and atherosclerotic plaque burden in mouse ...
St Jude researchers have demonstrated that deleting the Regnase-1 gene from CAR T cells significantly improves tumour control ...
PROTACs and molecular glues can both remove disease-associated proteins, but choosing between them is not simple. Our new ...
Five leading cancer researchers from across genomics, proteomics, cell biology, chemical biology and gene therapy dig into ...
A new preclinical study finds that combining the antibody-drug conjugate HER3-DXd with PARP inhibitor olaparib significantly ...
A new preclinical study published has identified BRAF as a key regulator of pain signalling after nerve injury, with existing ...
Discover how integrated technologies, multiomic approaches and AI are helping researchers translate complex biological ...
Professor Paul O’Reilly is a Professor in Statistical Genetics at the Icahn School of Medicine, Mount Sinai, New York. With a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results